Advertisement

Advertisement

LPCN Stock Latest News

Lipocine Advances LPCN 1154 for Postpartum Depression

Company AnnouncementsLipocine Advances LPCN 1154 for Postpartum Depression

Lipocine Shareholders Approve Directors, Auditor and Incentive Plan

PremiumCompany Announcements

Lipocine Shareholders Approve Directors, Auditor and Incentive Plan

18d ago

Lipocine Plans KOL Webinar on Oral PPD Candidate

PremiumCompany Announcements

Lipocine Plans KOL Webinar on Oral PPD Candidate

18d ago

Lipocine Showcases Phase 3 Data in Postpartum Depression

PremiumCompany Announcements

Lipocine Showcases Phase 3 Data in Postpartum Depression

27d ago

Lipocine Showcases Phase 3 Data for Postpartum Depression

PremiumCompany Announcements

Lipocine Showcases Phase 3 Data for Postpartum Depression

1M ago

Lipocine Showcases Pipeline at Virtual Healthcare Conference

PremiumCompany AnnouncementsLipocine Showcases Pipeline at Virtual Healthcare Conference

1M ago

Lipocine Updates Corporate Presentation for Investor Communications

Company Announcements

Lipocine Updates Corporate Presentation for Investor Communications

2M ago

LPCN Earnings this Week: How Will it Perform?

Pre-Earnings

LPCN Earnings this Week: How Will it Perform?

2M ago

Lipocine Reshapes Board Leadership Amid Strategic Shift

PremiumCompany Announcements

Lipocine Reshapes Board Leadership Amid Strategic Shift

2M ago

Lipocine price target lowered to $6 from $11 at Alliance Global

PremiumThe Fly

Lipocine price target lowered to $6 from $11 at Alliance Global

2M ago

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

PremiumThe Fly

Lipocine downgraded to Neutral from Buy at H.C. Wainwright

3M ago

Lipocine weighs path after LPCN 1154 Phase 3 miss

PremiumCompany Announcements

Lipocine weighs path after LPCN 1154 Phase 3 miss

3M ago

Lipocine Updates Investor Presentation to Refine Market Messaging

PremiumCompany AnnouncementsLipocine Updates Investor Presentation to Refine Market Messaging

3M ago

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

The Fly

Lipocine’s LPCN 1154 did not meet endpoint in postpartum depression trial

3M ago

Lipocine price target raised to $11 from $6.75 at Alliance Global

The Fly

Lipocine price target raised to $11 from $6.75 at Alliance Global

3M ago

Lipocine Files Prospectus to Enable $50M Stock Offering

PremiumCompany Announcements

Lipocine Files Prospectus to Enable $50M Stock Offering

4M ago

LPCN Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

LPCN Upcoming Earnings Report: What to Expect?

4M ago

Lipocine Completes Phase 3 Trial for Postpartum Depression

PremiumCompany Announcements

Lipocine Completes Phase 3 Trial for Postpartum Depression

4M ago

Lipocine Updates Investor Presentation to Reflect Latest Strategy

PremiumCompany Announcements

Lipocine Updates Investor Presentation to Reflect Latest Strategy

4M ago

Lipocine announces last patient visit in Phase 3 trial of LPCN 1154

PremiumThe FlyLipocine announces last patient visit in Phase 3 trial of LPCN 1154

4M ago

Lipocine price target raised to $15 from $7 at H.C. Wainwright

The Fly

Lipocine price target raised to $15 from $7 at H.C. Wainwright

5M ago

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

Company Announcements

Lipocine Completes Phase 3 Enrollment for Postpartum Depression Drug

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >